|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.25 GBX | 0.00% |
|
0.00% | -39.34% |
| Apr. 05 | SkinBioTherapeutics Gets Bond Conversion Notice from Macquarie | MT |
| Mar. 22 | SkinBioTherapeutics half-year revenue jumps on UK-based sales | AN |
SkinBioTherapeutics plc reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was GBP 0.106576 million compared to GBP 0.076985 million a year ago. Net loss was GBP 1.33 million compared to GBP 1.29 million a year ago.
Basic loss per share from continuing operations was GBP 0.0075 compared to GBP 0.0082 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.34% | 22.38M | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
SKINBIOTHERAPEUTICS PLC 
